Search Result "melatoninergic ligands"
In Search of Novel and Therapeutically Significant Melatoninergic Ligands
Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 2 Issue: 3 Year: 2007 Page: 241-245
Author(s): Sejal M. Mody, Yueqing Hu, Maurice K.C. Ho, Yung H. Wong
In Search of Novel and Therapeutically Significant Melatoninergic Ligands
Ebook: Frontiers in CNS Drug Discovery
Volume: 1 Year: 2010
Author(s): Sejal M. Mody, Yueqing Hu, Maurice K.C.Ho, Yung H. Wong
Doi: 10.2174/978160805159511001010600
Investigational Selective Melatoninergic Ligands for Receptor Subtype MT2
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13 Issue: 1 Year: 2013 Page: 1462-1474
Author(s): Ning Wan, Fang-Fang Zhang, Jia Ju, Dao-Zhou Liu, Si-Yuan Zhou, Bang-Le Zhang
Pharmaceutical and Nutritional Benefits in Alzheimers Disease via Convergence on the Melatoninergic Pathways
Ebook: Frontiers in Clinical Drug Research - Alzheimer Disorders
Volume: 4 Year: 2015
Author(s): George Anderson,Michael Maes
Doi: 10.2174/9781681081472115040004
Glioma: Tryptophan Catabolite and Melatoninergic Pathways Link microRNA, 14-3- 3, Chromosome 4q35, Epigenetic Processes and other Glioma Biochemical Changes
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 8 Year: 2016 Page: 1033-1048
Author(s): Timothy V. Beischlag,George Anderson,Gianluigi Mazzoccoli
Melatonin and Synthetic Melatoninergic Agonists in Psychiatric and Age-associated Disorders: Successful and Unsuccessful Approaches
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 8 Year: 2016 Page: 1086-1101
Author(s): Rüdiger Hardeland
Overlapping the Tryptophan Catabolite (TRYCAT) and Melatoninergic Pathways in Alzheimer's Disease
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 8 Year: 2016 Page: 1074-1085
Author(s): Michael Maes,George Anderson
Design and Synthesis of New N1 and C3-Substituted 4-Fluoroindolic Melatoninergics
Journal: Current Drug Discovery Technologies
Volume: 4 Issue: 3 Year: 2007 Page: 198-207
Author(s): Andrew Tsotinis, Andreas Eleutheriades, Kathryn Davidson, David Sugden, Andrew Tsotinis, Andreas Eleutheriades, Kathryn Davidson, David Sugden
Potent Lipophilic Melatoninergic x-fluoro-y-methoxy Substituted Phenylalkylamides:Molecular Dynamics Calculations and in vitro Modified Release inAqueous Media from Tablet Formulations
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 17 Year: 2023 Page: 1370-1378
Author(s):
Melatonin and Melatoninergic Drugs as Therapeutic Agents: Ramelteon and Agomelatine, the Two Most Promising Melatonin Receptor Agonists
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 1 Issue: 2 Year: 2007 Page: 142-151
Author(s): Emilio J. Sanchez-Barcelo, Carlos M. Martinez-Campa, Maria D. Mediavilla, Alicia Gonzalez, Carolina Alonso-Gonzalez, Samuel Cos